The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.

Experts at HLTH Europe 2026 agreed that healthcare innovations won't meet their full potential until healthcare services can implement them.

Artivion has received the PMA clearance from the US FDA for AMDS Hybrid Prosthesis device, permitting its use in treating acute DeBakey Type I aortic dissections with clinical or radiographic ...

Roche has introduced its Axelios 1 platform, a next-generation sequencing system that is available for research use and powered by its SBX technology.

The clinical AI platform is used in nearly 2,000 hospitals worldwide. Credit: Chinnapong / Shutterstock.com. The US Food and Drug Administration (FDA) has granted breakthrough device designation to ...

Accounting for up to 30% of strokes, carotid artery disease is characterised by plaque build-up in the arteries supplying the brain. Credit: Mehmet Cetin / Shutterstock.com. Johnson & Johnson (J&J) ...

Clariyon’s AI agent boosted physician sepsis care compliance by 13% in a clinical trial. Credit: ImageFlow / Shutterstock.com. Clariyon’s artificial intelligence (AI)-powered sepsis care agent has ...

Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients throughout the US.

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

HB Fuller says the AMS acquisition would expand its TAM by $15bn, while bringing in around $300m in extra annual revenue.

This authorisation will expand the B-Right AI platform’s use to Europe, as BrightHeart continues to roll the technology out across the US.